Diagnostic Radioisotopes Market

Diagnostic radiopharmaceuticals.Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for thediagnosis
Diagnostic Radioisotopes Market contains market size and forecasts of Diagnostic Radioisotopes in global, including the following market information:
Global Diagnostic Radioisotopes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diagnostic Radioisotopes Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Diagnostic Radioisotopes companies in 2021 (%)
The global Diagnostic Radioisotopes market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tc-99m Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diagnostic Radioisotopes include Bracco Imaging, Bayer, Curium Pharmaceuticals, Nordion, Triad Isotopes, Lantheus, GE Healthcare, China Isotope & Radiation and Jubilant Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diagnostic Radioisotopes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Tc-99m
• F-18
• Other

• Oncology
• Cardiology
• Other

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Diagnostic Radioisotopes revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Diagnostic Radioisotopes revenues share in global market, 2021 (%)
• Key companies Diagnostic Radioisotopes sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Diagnostic Radioisotopes sales share in global market, 2021 (%)

• Bracco Imaging
• Bayer
• Curium Pharmaceuticals
• Nordion
• Triad Isotopes
• Lantheus
• GE Healthcare
• China Isotope & Radiation
• Jubilant Pharma
• Eli Lilly
• Novartis
• SIEMENS
• Dongcheng
• Navidea